| 89 | Humans |
| 60 | Male |
| 42 | Indium Radioisotopes (diagnostic use) |
| 40 | Food |
| 40 | Adult |
| 37 | Female |
| 27 | Middle Aged |
| 23 | Pentetic Acid (diagnostic use) |
| 23 | Gastric Emptying |
| 23 | Animals |
| 20 | Technetium (diagnostic use) |
| 18 | Indium (diagnostic use) |
| 16 | Time Factors |
| 16 | Stomach (radionuclide imaging) |
| 16 | Radioisotopes (diagnostic use) |
| 15 | Gastric Emptying (physiology) |
| 14 | Technetium Tc 99m Sulfur Colloid (diagnostic use) |
| 13 | Aged |
| 11 | Gastric Emptying (drug effects) |
| 9 | Sensitivity and Specificity |
| 9 | Adolescent |
| 8 | Radiopharmaceuticals (diagnostic use) |
| 8 | Double-Blind Method |
| 7 | Tissue Distribution |
| 7 | Electrodes |
| 7 | Colon (physiology) |
| 7 | Antibodies, Monoclonal (diagnostic use) |
| 6 | United States |
| 6 | Tin Compounds (chemistry) |
| 6 | Stomach (physiology) |
| 6 | Gastrointestinal Transit (physiology) |
| 6 | Food Contamination (analysis) |
| 6 | Esophagus (radionuclide imaging) |
| 6 | Dogs |
| 6 | Child |
| 6 | Child, Preschool |
| 5 | United States Food and Drug Administration |
| 5 | Reference Values |
| 5 | Microspheres |
| 5 | Mice |
| 5 | Hydrogen-Ion Concentration |
| 5 | Gastrointestinal Transit |
| 5 | Gastrointestinal Motility (physiology) |
| 5 | Cross-Over Studies |
| 5 | Biosensing Techniques (methods) |
| 5 | Antibodies, Monoclonal (therapeutic use) |
| 4 | Tin Compounds |
| 4 | Reproducibility of Results |
| 4 | Prostatic Neoplasms (radionuclide imaging) |
| 4 | Octreotide (analogs & derivatives) |
| 4 | Indium Radioisotopes |
| 4 | Gold (chemistry) |
| 4 | Gastrointestinal Motility |
| 4 | Equipment Design |
| 4 | Electrochemistry (methods) |
| 4 | Electrochemistry (instrumentation) |
| 4 | Diabetes Mellitus, Type 1 (physiopathology) |
| 4 | Colon (radionuclide imaging) |
| 4 | Biosensing Techniques (instrumentation) |
| 4 | Beverages |
| 3 | Yttrium Radioisotopes (therapeutic use) |
| 3 | Tomography, X-Ray Computed |
| 3 | Technetium Tc 99m Pentetate (diagnostic use) |
| 3 | Stomach Diseases (radionuclide imaging) |
| 3 | Scattering, Radiation |
| 3 | Receptors, Somatostatin (genetics) |
| 3 | Receptors, Somatostatin (analysis) |
| 3 | Random Allocation |
| 3 | Radioimmunodetection |
| 3 | Radiation Dosage |
| 3 | Prostatic Neoplasms (radiotherapy) |
| 3 | Prostate-Specific Antigen (blood) |
| 3 | Polymers |
| 3 | Pentetic Acid (analogs & derivatives) |
| 3 | Organotechnetium Compounds (diagnostic use) |
| 3 | Octreotide (diagnostic use) |
| 3 | Nanoparticles (chemistry) |
| 3 | Models, Structural |
| 3 | Mice, Nude |
| 3 | Methods |
| 3 | Metals (analysis) |
| 3 | Intestine, Small (radionuclide imaging) |
| 3 | Intestine, Small (physiology) |
| 3 | Infant |
| 3 | Indium (metabolism) |
| 3 | Half-Life |
| 3 | Food, Formulated |
| 3 | Esophageal Neoplasms (radionuclide imaging) |
| 3 | Equipment Failure Analysis |
| 3 | Drug Approval |
| 3 | Digestive System (radionuclide imaging) |
| 3 | Diabetes Mellitus, Type 1 (complications) |
| 3 | Blood Preservation (methods) |
| 3 | Biosensing Techniques |
| 3 | Antibodies, Monoclonal (pharmacokinetics) |
| 3 | Administration, Oral |
| 2 | Wine (analysis) |
| 2 | Water (analysis) |
| 2 | Treatment Outcome |
| 2 | Tomography, Emission-Computed, Single-Photon |
| 2 | Tin Compounds (diagnostic use) |
| 2 | Tin (diagnostic use) |
| 2 | Thermodynamics |
| 2 | Technetium Tc 99m Sulfur Colloid |
| 2 | Technetium Tc 99m Pentetate |
| 2 | Technetium Compounds |
| 2 | Technetium Compounds (diagnostic use) |
| 2 | Technetium (pharmacokinetics) |
| 2 | Tablets |
| 2 | Tablets, Enteric-Coated |
| 2 | Sulfur (diagnostic use) |
| 2 | Sucrose (chemistry) |
| 2 | Stomach Diseases (physiopathology) |
| 2 | Stomach Diseases (etiology) |
| 2 | Stomach (physiopathology) |
| 2 | Stomach (metabolism) |
| 2 | Stomach (drug effects) |
| 2 | Spectrum Analysis (methods) |
| 2 | Spectrophotometry, Ultraviolet |
| 2 | Sex Characteristics |
| 2 | Retrospective Studies |
| 2 | Rats |
| 2 | Rats, Wistar |
| 2 | Radiopharmaceuticals (therapeutic use) |
| 2 | Radionuclide Imaging |
| 2 | Radionuclide Imaging (methods) |
| 2 | Radioisotopes |
| 2 | Radioimmunotherapy |
| 2 | Radioimmunodetection (methods) |
| 2 | Quantum Dots |
| 2 | Pylorus (surgery) |
| 2 | Prostatic Neoplasms (surgery) |
| 2 | Prostatic Neoplasms (pathology) |
| 2 | Prostatic Neoplasms (blood) |
| 2 | Prostatectomy |
| 2 | Postprandial Period |
| 2 | Postoperative Complications (physiopathology) |
| 2 | Polystyrenes |
| 2 | Phytic Acid (diagnostic use) |
| 2 | Peristalsis |
| 2 | Pentetic Acid (pharmacokinetics) |
| 2 | Pentanones |
| 2 | Papio |
| 2 | Pancreatin (administration & dosage) |
| 2 | Pancreatic Neoplasms (radionuclide imaging) |
| 2 | Oxyquinoline (diagnostic use) |
| 2 | Oxyquinoline (analogs & derivatives) |
| 2 | Oxidation-Reduction |
| 2 | Ovarian Neoplasms (radionuclide imaging) |
| 2 | Organometallic Compounds (diagnostic use) |
| 2 | Omeprazole (pharmacology) |
| 2 | Ochratoxins (analysis) |
| 2 | Neoplasms, Experimental (genetics) |
| 2 | Neoplasms, Experimental (diagnosis) |
| 2 | Neoplasms, Experimental (chemistry) |
| 2 | Neoplasm Staging |
| 2 | Meat |
| 2 | Mass Spectrometry |
| 2 | Magnetic Resonance Imaging |
| 2 | Lymphoma, Non-Hodgkin (radiotherapy) |
| 2 | Limit of Detection |
| 2 | Lead (analysis) |
| 2 | Kinetics |
| 2 | Kidney (metabolism) |
| 2 | Kidney (drug effects) |
| 2 | Isotope Labeling |
| 2 | Indium Radioisotopes (pharmacokinetics) |
| 2 | Indium Radioisotopes (administration & dosage) |
| 2 | Immunoassay (methods) |
| 2 | Immunoassay (instrumentation) |
| 2 | Ileum (physiology) |
| 2 | Hydrogen Peroxide (analysis) |
| 2 | Horseradish Peroxidase (chemistry) |
| 2 | Glucose (chemistry) |
| 2 | Germany |
| 2 | Gene Transfer Techniques |
| 2 | Gene Expression Regulation, Neoplastic |
| 2 | Gastrointestinal Transit (drug effects) |
| 2 | Gastrointestinal Motility (drug effects) |
| 2 | Gastrointestinal Hormones (secretion) |
| 2 | Gastrointestinal Hormones (blood) |
| 2 | Fructose (chemistry) |
| 2 | Formaldehyde (analysis) |
| 2 | Food Contamination |
| 2 | Food Analysis (methods) |
| 2 | Food Analysis (instrumentation) |
| 2 | Fasting |
| 2 | Fasting (physiology) |
| 2 | Evaluation Studies as Topic |
| 2 | Esophagus (physiology) |
| 2 | Esophageal Neoplasms (physiopathology) |
| 2 | Erythromycin (pharmacology) |
| 2 | Enzyme-Linked Immunosorbent Assay (methods) |
| 2 | Environmental Exposure |
| 2 | Electric Impedance |
| 2 | Eating (physiology) |
| 2 | Duodenum (physiology) |
| 2 | Duodenal Ulcer (surgery) |
| 2 | Duodenal Ulcer (radionuclide imaging) |
| 2 | Duodenal Ulcer (drug therapy) |
| 2 | Dumping Syndrome (etiology) |
| 2 | Dumping Syndrome (diagnosis) |
| 2 | Drug Delivery Systems |
| 2 | Delayed-Action Preparations |
| 2 | Cystic Fibrosis (radionuclide imaging) |
| 2 | Cystic Fibrosis (physiopathology) |
| 2 | Crohn Disease (diet therapy) |
| 2 | Colorimetry (methods) |
| 2 | Colonic Neoplasms (radionuclide imaging) |
| 2 | Clinical Trials as Topic |
| 2 | Chromium (analysis) |
| 2 | Chimera |
| 2 | Cell Survival |
| 2 | Capsules |
| 2 | Breath Tests |
| 2 | Blood Volume |
| 2 | Blood Platelets (cytology) |
| 2 | Blood Glucose (metabolism) |
| 2 | Blood Glucose (analysis) |
| 2 | Bile (physiology) |
| 2 | Barium Sulfate (diagnostic use) |
| 2 | Antigens, CD20 (immunology) |
| 2 | Antibodies, Monoclonal, Murine-Derived |
| 2 | Anti-Ulcer Agents (pharmacology) |
| 2 | Antacids (pharmacokinetics) |
| 2 | Animal Feed |
| 2 | Aflatoxin B1 (immunology) |
| 2 | Aflatoxin B1 (analysis) |
| 1 | Zirconium (metabolism) |
| 1 | Zinc Oxide (chemistry) |
| 1 | Zinc Isotopes (metabolism) |
| 1 | Yttrium Radioisotopes |
| 1 | Yttrium Radioisotopes (pharmacokinetics) |
| 1 | Yttrium (metabolism) |
| 1 | Young Adult |
| 1 | X-Ray Diffraction |
| 1 | Wine (classification) |
| 1 | Whole-Body Counting |
| 1 | Whole Body Imaging |
| 1 | Water |
| 1 | Water Pollution, Radioactive |
| 1 | Water Pollution (statistics & numerical data) |
| 1 | Water Pollution (analysis) |
| 1 | Water (chemistry) |
| 1 | Verapamil (pharmacology) |
| 1 | Vagotomy |
| 1 | Vagotomy, Proximal Gastric (adverse effects) |
| 1 | Vagotomy (adverse effects) |
| 1 | Vacuoles (ultrastructure) |
| 1 | Uric Acid (blood) |
| 1 | Transition Temperature |
| 1 | Transferrin (metabolism) |
| 1 | Trace Elements (blood) |
| 1 | Trace Elements (analysis) |
| 1 | Tomography, Emission-Computed, Single-Photon (methods) |
| 1 | Tomography, Emission-Computed (methods) |
| 1 | Titanium (chemistry) |
| 1 | Tin (analysis) |
| 1 | Thiocyanates (diagnostic use) |
| 1 | Thiazoles (diagnostic use) |
| 1 | Theophylline (pharmacokinetics) |
| 1 | Theophylline (analysis) |
| 1 | Theophylline (administration & dosage) |
| 1 | Testis (ultrastructure) |
| 1 | Testis (metabolism) |
| 1 | Tellurium (chemistry) |
| 1 | Technology Assessment, Biomedical |
| 1 | Technetium Tc 99m Pyrophosphate (diagnostic use) |
| 1 | Technetium Tc 99m Medronate (diagnostic use) |
| 1 | Technetium (administration & dosage) |
| 1 | Tea (chemistry) |
| 1 | Synephrine (analysis) |
| 1 | Swine |
| 1 | Survival Rate |
| 1 | Surface Properties |
| 1 | Sulfuric Acids (chemistry) |
| 1 | Sucralfate (therapeutic use) |
| 1 | Succinimides |
| 1 | Strontium Isotopes (metabolism) |
| 1 | Stomach Neoplasms (radionuclide imaging) |
| 1 | Stomach Neoplasms (physiopathology) |
| 1 | Stomach Diseases (radiography) |
| 1 | Stomach Diseases (drug therapy) |
| 1 | Stomach (surgery) |
| 1 | Stomach (radiography) |
| 1 | Stearic Acids |
| 1 | Statistics, Nonparametric |
| 1 | Staining and Labeling |
| 1 | Spectrum Analysis, Raman |
| 1 | Spectrum Analysis, Raman (methods) |
| 1 | Spectroscopy, Fourier Transform Infrared |
| 1 | Spectrophotometry, Atomic (methods) |
| 1 | Solutions (chemistry) |
| 1 | Solubility |
| 1 | Sodium Pertechnetate Tc 99m (diagnostic use) |
| 1 | Sodium Bicarbonate |
| 1 | Silicon Dioxide (administration & dosage) |
| 1 | Silicic Acid (pharmacokinetics) |
| 1 | Silicic Acid (administration & dosage) |
| 1 | Sensory Receptor Cells (physiology) |
| 1 | Semiconductors |
| 1 | Secretory Rate |
| 1 | Scleroderma, Systemic (radionuclide imaging) |
| 1 | Scleroderma, Systemic (physiopathology) |
| 1 | Scintillation Counting |
| 1 | Scandium (metabolism) |
| 1 | Salvage Therapy |
| 1 | Salivation (drug effects) |
| 1 | Saliva (chemistry) |
| 1 | Safety |
| 1 | Rosales |
| 1 | Risk Factors |
| 1 | Risk Assessment |
| 1 | Risk Assessment (methods) |
| 1 | Renal Dialysis (adverse effects) |
| 1 | Registries |
| 1 | Recurrence |
| 1 | Rectal Neoplasms (radionuclide imaging) |
| 1 | Rectal Neoplasms (pathology) |
| 1 | Recombinant Fusion Proteins (metabolism) |
| 1 | Receptors, Somatostatin (metabolism) |
| 1 | Receptors, Peptide (metabolism) |
| 1 | Randomized Controlled Trials as Topic |
| 1 | Radiotherapy Dosage |
| 1 | Radiopharmaceuticals (pharmacokinetics) |
| 1 | Radiopharmaceuticals (adverse effects) |
| 1 | Radiopharmaceuticals (administration & dosage) |
| 1 | Radioisotopes (metabolism) |
| 1 | Radioimmunotherapy (methods) |
| 1 | Radioimmunodetection (instrumentation) |
| 1 | Radioactive Waste |
| 1 | Radiation Protection |
| 1 | Radiation Effects |
| 1 | Quality Control |
| 1 | Pyrroles |
| 1 | Pylorus |
| 1 | Pylorus (physiology) |
| 1 | Pulse (drug effects) |
| 1 | Pulmonary Embolism (radionuclide imaging) |
| 1 | Proton Pump Inhibitors |
| 1 | Prostatic Neoplasms (diagnosis) |
| 1 | Prospective Studies |
| 1 | Propantheline (pharmacology) |
| 1 | Propantheline (adverse effects) |
| 1 | Process Assessment (Health Care) |
| 1 | Prevalence |
| 1 | Pressure |
| 1 | Predictive Value of Tests |
| 1 | Posture |
| 1 | Postprandial Period (physiology) |
| 1 | Postoperative Complications |
| 1 | Postoperative Complications (radionuclide imaging) |
| 1 | Positron-Emission Tomography (methods) |
| 1 | Porosity |
| 1 | Polystyrenes (diagnostic use) |
| 1 | Polystyrenes (chemistry) |
| 1 | Polymethacrylic Acids |
| 1 | Plateletpheresis |
| 1 | Platelet-Rich Plasma |
| 1 | Platelet Transfusion |
| 1 | Platelet Glycoprotein GPIb-IX Complex (analysis) |
| 1 | Platelet Activation |
| 1 | Plasma (chemistry) |
| 1 | Plant Oils (metabolism) |
| 1 | Plant Extracts (pharmacology) |
| 1 | Piperidines (pharmacology) |
| 1 | Photons |
| 1 | Photochemistry |
| 1 | Phosphines (toxicity) |
| 1 | Pesticides (analysis) |
| 1 | Pepsin A (secretion) |
| 1 | Pentetic Acid (chemistry) |
| 1 | Pentetic Acid (adverse effects) |
| 1 | Pentetic Acid (administration & dosage) |
| 1 | Pectins (pharmacology) |
| 1 | Patch Tests |
| 1 | Particle Size |
| 1 | Parkinson Disease (etiology) |
| 1 | Parenteral Nutrition, Total |
| 1 | Paralysis (radionuclide imaging) |
| 1 | Paralysis (physiopathology) |
| 1 | Paralysis (drug therapy) |
| 1 | Paper |
| 1 | Pancreatin (physiology) |
| 1 | Pancreatin (pharmacokinetics) |
| 1 | Pancreaticoduodenectomy (methods) |
| 1 | Pancreatic Neoplasms (surgery) |
| 1 | Pancreatic Neoplasms (pathology) |
| 1 | Pancreatic Juice (secretion) |
| 1 | Pancreatectomy |
| 1 | Pancreas (blood supply) |
| 1 | P-Selectin (analysis) |
| 1 | Oxygen Consumption |
| 1 | Oxidoreductases (analysis) |
| 1 | Oxides (chemistry) |
| 1 | Oxidative Stress |
| 1 | Oxidants (metabolism) |
| 1 | Outcome Assessment (Health Care) |
| 1 | Osteomalacia (etiology) |
| 1 | Organotechnetium Compounds |
| 1 | Organometallic Compounds |
| 1 | Organ Specificity |
| 1 | Optics and Photonics |
| 1 | Oocysts (growth & development) |
| 1 | Oligopeptides (diagnostic use) |
| 1 | Oligopeptides (chemistry) |
| 1 | Oligopeptides (adverse effects) |
| 1 | Oligonucleotides (chemistry) |
| 1 | Oils (metabolism) |
| 1 | Oils (administration & dosage) |
| 1 | Octreotide (pharmacokinetics) |
| 1 | Oceanography |
| 1 | Nutritional Status |
| 1 | Nucleic Acid Hybridization (methods) |
| 1 | Nondisjunction, Genetic (drug effects) |
| 1 | Nitric Acid (chemistry) |
| 1 | Niobium (metabolism) |
| 1 | Nickel |
| 1 | Neuroendocrine Tumors (radionuclide imaging) |
| 1 | Neoplasms, Experimental (metabolism) |
| 1 | Neoplasm Transplantation |
| 1 | Neoplasm Recurrence, Local (therapy) |
| 1 | Neoplasm Recurrence, Local (radiotherapy) |
| 1 | Neoplasm Recurrence, Local (diagnosis) |
| 1 | Nausea (physiopathology) |
| 1 | Nausea (etiology) |
| 1 | Nanotubes (chemistry) |
| 1 | Nanotechnology |
| 1 | Nanotechnology (methods) |
| 1 | Nanostructures |
| 1 | Nanoparticles (ultrastructure) |
| 1 | Nandrolone (analysis) |
| 1 | Nandrolone (analogs & derivatives) |
| 1 | Myoelectric Complex, Migrating (physiology) |
| 1 | Muscular Dystrophies (etiology) |
| 1 | Muscarinic Antagonists (pharmacology) |
| 1 | Mouth Diseases (etiology) |
| 1 | Mouth Diseases (diagnosis) |
| 1 | Motilin (blood) |
| 1 | Monocytes (transplantation) |
| 1 | Monocytes (physiology) |
| 1 | Monitoring, Physiologic (methods) |
| 1 | Molecular Structure |
| 1 | Molecular Imaging |
| 1 | Misoprostol |
| 1 | Milk |
| 1 | Microwaves |
| 1 | Microtubules (drug effects) |
| 1 | Microscopy, Electron, Transmission |
| 1 | Microscopy, Electron, Scanning |
| 1 | Micromanipulation (methods) |
| 1 | Microarray Analysis (instrumentation) |
| 1 | Mice, Transgenic |
| 1 | Mice, Knockout |
| 1 | Metoclopramide (therapeutic use) |
| 1 | Metoclopramide (pharmacology) |
| 1 | Methacrylates |
| 1 | Metals (toxicity) |
| 1 | Metal Nanoparticles (ultrastructure) |
| 1 | Metal Nanoparticles (chemistry) |
| 1 | Mesalamine |
| 1 | Mercury (analysis) |
| 1 | Membranes, Artificial |
| 1 | Membrane Proteins (metabolism) |
| 1 | Membrane Lipids (metabolism) |
| 1 | Meat Products |
| 1 | Maximum Allowable Concentration |
| 1 | Mathematics |
| 1 | Mass Spectrometry (methods) |
| 1 | Manometry |
| 1 | Maleates (pharmacology) |
| 1 | Magnetics (methods) |
| 1 | Lysine (pharmacology) |
| 1 | Lymphoma, Non-Hodgkin (radionuclide imaging) |
| 1 | Lymphoma, Non-Hodgkin (metabolism) |
| 1 | Lymphoma, Non-Hodgkin (drug therapy) |
| 1 | Lymphoma, B-Cell (therapy) |
| 1 | Lymphoma, B-Cell (immunology) |
| 1 | Lymphatic Metastasis |
| 1 | Lung Neoplasms (radionuclide imaging) |
| 1 | Lung Neoplasms (metabolism) |
| 1 | Lung Neoplasms (chemically induced) |
| 1 | Lung Diseases (radionuclide imaging) |
| 1 | Lung (metabolism) |
| 1 | Luminescent Measurements |
| 1 | Luminescent Measurements (instrumentation) |
| 1 | Lovastatin (therapeutic use) |
| 1 | Liver |
| 1 | Liver Function Tests |
| 1 | Liver Diseases (physiopathology) |
| 1 | Listeria monocytogenes (isolation & purification) |
| 1 | Lipase (administration & dosage) |
| 1 | Linear Models |
| 1 | Lichen Planus, Oral (etiology) |
| 1 | Lichen Planus, Oral (chemically induced) |
| 1 | Leukocytes |
| 1 | Leukocytes (metabolism) |
| 1 | Lectins |
| 1 | Lead Poisoning (metabolism) |
| 1 | Lactulose (diagnostic use) |
